4160084/2025 - ISONIAZID 300 MG COMP

This tender, identified by reference number 4160084/2025, concerns the acquisition of Isoniazid 300 mg tablets (COMP likely stands for Comprimidos, meaning tablets). Isoniazid is a first-line medication used for the prevention and treatment of tuberculosis (TB). It is an antibiotic that works by stopping the growth of bacteria that cause TB. The objective of this procurement is to secure a supply of this essential drug, likely for a public health program focused on tuberculosis control or for a healthcare facility treating patients with TB. The tender will specify the required quantity, quality standards (e.g., pharmacopeial compliance), packaging, and delivery timelines. Bidders will be evaluated based on their ability to provide high-quality Isoniazid tablets at a competitive price, ensuring compliance with all regulatory requirements for pharmaceutical products. This procurement is vital for ongoing efforts to combat tuberculosis and ensure that patients have access to effective treatment.

This is a supplies contract in the health and medical services, information and communication technology and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 1,940.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.